trending Market Intelligence /marketintelligence/en/news-insights/trending/iyrncwsy4ke3qv_z3urwlq2 content esgSubNav
In This List

Abeona adds 2 directors, replaces another

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Abeona adds 2 directors, replaces another

Abeona Therapeutics Inc. appointed CEO F. Carsten Thiel to be a director on its board.

Thiel, who was appointed CEO in March, replaces Timothy Miller who will continue to serve as the company's chief scientific officer and president.

The Dallas-based clinical-stage biopharmaceutical company also appointed Stefano Buono and Richard Van Duyne to the board.